2021 Latin America Coagulation Testing 22-County Market Assessment—Chromogenic, Immunodiagnostic, Molecular Test Volume and Sales Segment Forecasts--Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This new 22-country report is available by country, market segment, section, or individual test.

The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The report is available by section, and can be customized to specific information needs and budget.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests Analyzed in the Report

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others.

Country Analyses

Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Companies developing or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- Ideal product models with tentative prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.



I. Introduction
II. Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen

18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Coagulation Instrumentation Review: Centralized
And POC Testing Analyzers
C. Major Coagulation Testing Technologies
And Their Potential Applications
VIII. 22-Country Market Analyses: Market Size, Reagent and Instrument Sales Forecasts, Volume
Projections for 40 Procedures, Supplier Sales and Market Shares
IX. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation market
players and start-up companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others

List Of Tables


Argentina Coagulation Test Volume
Forecasts by Procedure
Argentina Coagulation Diagnostics Market
by Product Category
Bolivia Coagulation Test Volume
Forecasts by Procedure
Bolivia Coagulation Diagnostics Market
by Product Category
Brazil Coagulation Test Volume
Forecasts by Procedure
Brazil Coagulation Diagnostics Market
by Product Category
Chile Coagulation Test Volume
Forecasts by Procedure
Chile Coagulation Diagnostics Market
by Product Category
Colombia Coagulation Test Volume
Forecasts by Procedure
Colombia Coagulation Diagnostics Market
by Product Category
Costa Rica Coagulation Test Volume
Forecasts by Procedure
Costa Rica Coagulation Diagnostics
Market by Product Category
Cuba Coagulation Test Volume
Forecasts by Procedure
Cuba Coagulation Diagnostics Market
by Product Category
Dominican Republic Coagulation Test Volume
Forecasts by Procedure
Dominican Republic Coagulation
Diagnostics Market by Product Category

Ecuador Coagulation Test Volume
Forecasts by Procedure
Ecuador Coagulation Diagnostics
Market by Product Category
El Salvador Coagulation Test Volume
Forecasts by Procedure
El Salvador Coagulation Diagnostics
Market by Product Category
Guatemala Coagulation Test Volume
Forecasts by Procedure
Guatemala Coagulation Diagnostics
Market by Product Category
Haiti Coagulation Test Volume
Forecasts by Procedure
Haiti Coagulation Diagnostics Market by
Product Category
Honduras Coagulation Test Volume
Forecasts by Procedure
Honduras Coagulation Diagnostics
Market by Product Category
Jamaica Coagulation Test Volume
Forecasts by Procedure
Jamaica Coagulation Diagnostics Market
by Product Category
Mexico Coagulation Test Volume
Forecasts by Procedure
Mexico Coagulation Diagnostics Market
by Product Category
Nicaragua Coagulation Test Volume
Forecasts by Procedure
Nicaragua Coagulation Diagnostics
Market by Product Category

Panama Coagulation Test Volume
Forecasts by Procedure
Panama Coagulation Diagnostics
Market by Product Category
Paraguay Coagulation Test Volume
Forecasts by Procedure
Paraguay Coagulation Diagnostics
Market by Product Category
Peru Coagulation Test Volume
Forecasts by Procedure
Peru Coagulation Diagnostics Market
by Product Category
Puerto Rico Coagulation Test Volume
Forecasts by Procedure
Puerto Rico Coagulation Diagnostics
Market by Product Category
Uruguay Coagulation Test Volume
Forecasts by Procedure
Uruguay Coagulation Diagnostics
Market by Product Category
Venezuela Coagulation Test Volume
Forecasts by Procedure
Venezuela Coagulation Diagnostics Market
by Product Category
Major Companies Developing or Marketing
Activated Clotting Time Tests
Major Companies Developing or
Marketing APTT Tests
Major Companies Developing or Marketing
Alpha-2 Antiplasmin Tests

Major Companies Developing or Marketing
Antithrombin III Tests
Major Companies Developing or
Marketing Bleeding Time Tests
Major Companies Developing or
Marketing D-dimer Tests
Major Companies Developing or
Marketing Factor Assays
Major Companies Developing or Marketing
Fibrin Degradation Product Tests
Major Companies Developing or
Marketing Fibrinogen Tests
Major Companies Developing or
Marketing Heparin Tests
Major Companies Developing or
Marketing Plasmin Tests
Major Companies Developing or
Marketing Plasminogen Tests
Major Companies Developing or
Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing
Platelet Aggregation Tests
Major Companies Developing or
Marketing Protein C Tests
Major Companies Developing or
Marketing Protein S Tests
Major Companies Developing or
Marketing PT Tests
Major Companies Developing or
Marketing Thrombin Time Tests

Major Companies Developing or
Marketing TPA Tests
Major Companies Developing or Marketing
Von Willebrands Factor Tests

2021 Netherlands Tumor Marker Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Netherlands Tumor Marker Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 Myanmar Tumor Marker Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Myanmar Tumor Marker Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 Latin America Tumor Markers Market Assessment of 22 Countries--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Latin America Tumor Markers Market Assessment of 22 Countries--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 14500

USD 14500 View Report

2021 Latin America Transfusion Diagnostics Market Assessment of 22 Countries--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Latin America Transfusion Diagnostics Market Assessment of 22 Countries--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 14,500

USD 14,500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available